A senior aide to Rep. Colleen W. Hanabusa (D-Hawaii) told his colleagues late last month that the nation’s top drug lobby had agreed to run a campaign supporting the congresswoman’s challenge to Democratic Sen. Brian Schatz and wanted to coordinate it with her strategists.

Such an effort, described in an e-mail obtained by The Washington Post, could run afoul of campaign finance laws, which prohibit candidates and their staff from substantial discussions with interest groups about their independent political activities.

Officials with the Pharmaceutical Research and Manufacturers of America (PhRMA) and Hanabusa’s campaign denied that the group had offered to run such an effort but acknowledged talks about a possible fundraiser for Hanabusa and about the state of the race in general.

Campaign officials blamed the e-mail on a misinformed staffer.

“He made inaccurate assumptions about the type of help PhRMA could provide the campaign,” campaign spokesman Peter Boylan said. …

Read Civil Beat’s related report, Hanabusa And Schatz Differ Over Making Drug Companies Pay, by Kery Murakami.

Photo: Drugs and money. (Flickr: Images of Money)

—Chad Blair